Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Jan;27(1):339-47.
doi: 10.1007/s00198-015-3365-x.

Proton-pump inhibitors and risk of fractures: an update meta-analysis

Meta-Analysis

Proton-pump inhibitors and risk of fractures: an update meta-analysis

B Zhou et al. Osteoporos Int. 2016 Jan.

Abstract

To identify the relationship between proton-pump inhibitors (PPIs) and the risk of fracture, we conducted an update meta-analysis of observational studies. Results showed that PPI use was associated with a modestly increased risk of hip, spine, and any-site fracture.

Introduction: Many studies have investigated the association of proton-pump inhibitors (PPIs) with fracture risk, but the results have been inconsistent. To evaluate this question, we performed a meta-analysis of relevant observational studies.

Methods: A systematic literature search up to February 2015 was performed in PubMed. We combined relative risks (RRs) for fractures using random-effects models and conducted subgroup and stratified analyses.

Results: Eighteen studies involving a total of 244,109 fracture cases were included in this meta-analysis. Pooled analysis showed that PPI use could moderately increase the risk of hip fracture [RR = 1.26, 95 % confidence intervals (CIs) 1.16–1.36]. There was statistically significant heterogeneity among studies (p < 0.001; I 2 = 71.9 %). After limiting to cohort studies, there was also a moderate increase in hip fracture risk without evidence of study heterogeneity. Pooling revealed that short-term use (<1 year) and longer use (>1 year) were similarly associated with increased risk of hip fracture. Furthermore, a moderately increased risk of spine (RR = 1.58, 95 % CI 1.38–1.82) and any-site fracture (RR = 1.33, 95 % CI 1.15–1.54) was also found among PPI users.

Conclusion: In this update meta-analysis of observational studies, PPI use modestly increased the risk of hip, spine, and any-site fracture, but no evidence of duration effect in subgroup analysis.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Am J Med. 2011 Jun;124(6):519-26 - PubMed
    1. Am J Gastroenterol. 2011 Jul;106(7):1209-18; quiz 1219 - PubMed
    1. J Bone Miner Res. 2010 Oct;25(10):2205-11 - PubMed
    1. Stat Med. 2002 Jun 15;21(11):1539-58 - PubMed
    1. Pharmacotherapy. 2008 Aug;28(8):951-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources